InvestorsHub Logo
Followers 7
Posts 564
Boards Moderated 0
Alias Born 08/27/2014

Re: jessellivermore post# 40290

Friday, 12/26/2014 10:28:50 AM

Friday, December 26, 2014 10:28:50 AM

Post# of 425913
Funny you should say that JL, I was thinking the same thing as i was typing my first response...just go generic. Actually though if you are amarin mgmt with limited resources, the only thing you can control is pricing, since their budget is limited for advertising and feet on the street. So if you could adjust pricing so that it came out cheaper than tier one generic. I mean it really does come down to adopting a strategy with limited resources that increase scripts substantially, and when people are thinking expansion outside of USA, that takes money, or of course we could pay the right people in the FDA like our competition does, but again that takes money...it would be great though to hear what's really been going on in the case of acquiring a partner...is there no interest? Or the price too steep..(think shark tank)? ??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News